Rachelle S. Doody, M.D., Ph.D.

Click on the Expand plus sign sign for the listing of news and events by year. Then click on the link for details or press release.


Collapse All | Expand All


Best of the best in care: Meet Houston's Top Doctors 2016 Oct. 21, 2016
Excellence in health care is a way of life in Houston. The MedCity section has looked to a list of America's Top Doctors, compiled by industry specialist Castle Connolly, to identify America's Top Doctors located right here in the Houston area. They exemplify excellence in Houston medicine.
At Alzheimer's meeting, firms take page from Silver Linings Playbook July 29, 2016
The big drug news from the annual Alzheimer's Association meeting this week involved companies that have found silver linings in otherwise gloomy data.
Stop undertreating Alzheimer's disease July 29, 2016
Diagnosing Alzheimer's disease early and beginning treatment can help preserve and maintain memory and thinking skills. But this often doesn't happen.
Dementia: Is new drug a major breakthrough? July 28, 2016
LMTX slows Alzheimer's progression - but it doesn't work on everyone and experts are urging caution
Alzheimer's drug LMTX falters in final stage of trials July 27, 2016
The drug did work on a handful of patients taking it alone, without another medication. But some experts were skeptical about the small subset.
Treat Alzheimer's patients now, researchers say as conference opens in T.O. July 26, 2016
Report says reluctance to use medications that "only" treat symptoms while awaiting new ones that deal with the disease is misplaced.
Immediate changes needed to Alzheimer's management, experts say July 25, 2016
Physicians recognized for their contributions to clinical research and advances in the treatment of people with Alzheimer's have called for immediate changes to how healthcare professionals approach the management of the disease.
Alzheimer's experts call for end to under-treatment of disease July 24, 2016
Doctors say evidence supports use of current drugs, evaluation of new cholinergic medicines that address cognition and function, not just focus on research for cure.
Dr. Rachelle Doody to give "Update on Alzheimer's Disease" lecture Sept. 24, 2015
The Houston community will have an opportunity to hear one of the leading researchers on Alzheimer's disease discuss the latest research on the disease at the annual "Update on Alzheimer's Disease" lecture.
Two minds on amyloid Aug. 17, 2015
Two experts take similar views on the amyloid hypothesis, but differ on how to move forward
Biogen reports its Alzheimer's drug sharply slowed cognitive decline March 30, 2015
The drug, developed by Biogen Idec, could achieve sales of billions of dollars a year if the results from the small trial are replicated in larger trials.
Dextromethorphan/quinidine combo controls PBA in dementia Dec. 2, 2014
A preparation of dextromethorphan and quinidine reduced the frequency of pseudobulbar affect (uncontrollable episodes of laughing or crying) in patients with dementia, a study shows.
Annual Alzheimer's update focuses on early detection Nov. 14, 2014
As research continues on how to best treat Alzheimer's disease, it is becoming clearer that identifying the disease in its earliest stages, or even before symptoms start, is key…
Today: BCM Alzheimer's expert to host updates on the disease at open lecture Nov. 10, 2014
Baylor College of Medicine Alzheimer's expert, Rachelle Doody, will host updates on the disease, and its research at an open lecture, on Monday, Nov, 10.
Dr. Rachelle Doody to give "Update on Alzheimer's Disease" lecture Nov. 6, 2014
The Houston community will have an opportunity to hear one of the leading researchers on Alzheimer's disease discuss the latest research on the disease at the annual "Update on Alzheimer's Disease" lecture Nov. 10, 2014.
Roche reports mixed results in trial of an Alzheimer's drug July 16, 2014
While the drug, crenezumab, did not slow progression of the disease over all, at the highest doses it seemed to delay a decline in mental ability in patients with mild Alzheimer's.
AZTherapies cleared to start enrolling under their IND for a Phase III clinical efficacy study for ALZT-OP1 in early Alzheimer's disease May 23, 2014
AZTherapies, Inc. a company developing novel treatments for Alzheimer's disease based on technology licensed from Massachusetts General Hospital, announced that it has received notice from FDA that it may proceed with the Phase III clinical study submitted in its IND application.
CereSpir Incorporated announces the inauguration of its clinical advisory board Feb. 21, 2014
CereSpir™ Incorporated, a company developing the first-in-class microglial modulator CHF 5074 as a potential treatment for Alzheimer's disease (AD), today announced the inauguration of its Clinical Advisory Board (CAB).
Lessons learned in BCM Alzheimer's drug trial move research forward Jan. 23, 2014
A group of researchers led by Baylor College of Medicine completed clinical trials with an Alzheimer's drug Solanezumab that had showed promising results in studies conducted in animals, only to find that the drug did not improve cognition or functional ability in those with mild to moderate Alzheimer's disease.
Lessons learned in Alzheimer's drug trial move research forward Jan. 22, 2014
Results of Baylor study could help move the field of Alzheimer's drug research forward with more targeted studies.
Clinical worsening shown in AD patients taking semagacestat July 26, 2013
Authors of a phase 3 study of the experimental drug, now published, say the disappointing results call for careful further analysis of the data to see why some patients deteriorated on treatment.
Alzheimer's disease research registry in the works July 19, 2013
The Alzheimer's Disease and Memory Disorder Center at Baylor College of Medicine has begun developing a registry of people in the Houston area who might be interested in participating in future Alzheimer's disease prevention research.
Some risk factors for Alzheimer's may be within your control March 25, 2013
Simple lifestyle changes may help prevent or delay not only heart disease but Alzheimer's disease, too.
Difficulty identifying Alzheimer's makes misdiagnosis easy Nov. 23, 2012
The doctors suspected Alzheimer's as well, or Parkinson's, but the drugs they prescribed did nothing to slow the progression of Shillcutt's symptoms, soon also including inattention, disorientation and incontinence.
Dr. Rachelle Doody to give Update on Alzheimer's Disease lecture Oct. 17, 2012
BCM's Dr. Doody to present annual update on Alzheimer's Disease during Oct. 25 lecture.
Three drugs to be tested to stave off Alzheimer's Oct. 10, 2012
Three studies are starting early next year with the same goal: finding a way to head off the disease with early intervention.
BIOTECH – Alzheimer's drug looks promising Oct. 8, 2012
Eli Lilly & Co.'s experimental Alzheimer's treatment, solanezumab, slowed memory loss and cognitive decline in early-stage patients by about 30 percent, offering the first evidence that a medication may hamper the course of the ailment, researchers said.
Eli Lilly drug shows promise in treating mild Alzheimer's Oct. 8, 2012
Results from two studies of Eli Lilly's solanezumab suggested it may slow mental decline, but doctors said another study was probably necessary for federal approval.
Doody will present Update on Alzheimer's Disease Sept. 24, 2012
Small trial hints drug can slow Alzheimer's July 17, 2012
Some Alzheimer's patients who used the therapy, already approved for immune disorders, showed no worsening of symptoms for three years.
More evidence omega-3 rich diet may protect aging brain Feb. 27, 2012
A study found that older adults with lower blood levels of omega-3 fatty acids had lower brain volumes and performed worse on certain cognitive tests than their peers with higher levels.
Could stimulating the brain one day treat Alzheimer's disease? Feb. 8, 2012
In a very small group of patients, sending electrical impulses to a memory-center in the brain -- via tiny implanted electrodes -- may have improved their memory.
Beta amyloid alters cognition even in healthy adults Feb. 6, 2012
About 20% of participants older than 60 years in a new study had amyloid accumulations.
New blood test to help diagnose Alzheimer's Jan. 7, 2011
Local doctors are working with other Texas researchers on a blood test to find Alzheimer's disease early.
Doody to present Alzheimer's lecture Oct. 1, 2010
Dr. Rachelle Doody, professor of neurology and director of the Alzheimer's Disease and Memory Disorders Center at BCM, will be the featured speaker at this year's "Update on Alzheimer's Disease" lecture.
Texas scientists on verge of Alzheimer's blood test July 26, 2010
Texas scientists are on the verge of developing a blood test to identify patients with Alzheimer's disease, a potential major breakthrough in the still difficult-to-diagnose ailment. The test, details of which were presented at an international conference…
Assessment predicts progression of Alzheimer's Disease Feb. 24, 2010
An assessment that reliably predicts the progression of Alzheimer's disease has been developed by researchers at Baylor College of Medicine.
BCM tackles Alzheimer's on all fronts Jan. 6, 2010
What causes Alzheimer's disease and how do we halt and reverse the damaging effects?
BCM to analyze data collected for Alzheimer's genetic markers project Jan. 6, 2010
BCM researchers look to genetic markers to understand Alzheimer's Disease risk.
Evening with Genetics: Update on Alzheimer's disease Nov. 19, 2009
Alzheimer's Disease and Memory Disorders Center will host annual healthy aging seminar Nov. 6, 2009
Doody receives Rice alumni award Sept. 15, 2009
Rice University Alumni Association recognizes Dr. Doody, who has advanced the interest and standards of excellence of Rice through her distinctive professional career.
Update on Alzheimer's disease Aug. 27, 2009
BCM has big showing of Health Care Hero finalists May 20, 2009
Baylor College of Medicine congratulates the faculty, physicians, alumni, and clinical staff who have been recognized as finalists for the 2009 Health Care Heroes Awards by the Houston Business Journal.
Commentary: Time is key in Alzheimer's research May 17, 2009
Adding to this sense of urgency are the severe financial and emotional challenges facing Alzheimer's patients and their families, not to mention the shortage of Alzheimer's clinical care options and community-based support services for caregivers. Over the next two years, our consortium plans to take Alzheimer's research to the next level…
Rice alumni association honors nine May 6, 2009
Rice alumni association honors nine. Cites contributions to university and the world.
Alumni recognized for distinguished achievements May 4, 2009
Three Rice University graduates have been selected to receive the Association…
How important is it to get treated early for Alzheimer's disease? May 4, 2009
It's very important that any symptoms of memory loss or thinking difficulties be assessed and if there is a problem, its important to know about that as early as possible. It's important both for instituting treatment and also making sure that the person doesn't go on any treatments for other…
What types of clinical trials are ongoing for Alzheimer's disease treatment, and should I be taking part in them? May 4, 2009
There are numerous clinical trials going on for people with Alzheimer's disease. And the drugs and interventions that are tested in these clinical trials are really quite diverse. So there are therapies under study that relate to neurotransmitters in the brain -- chemicals that are involved in…
A daughter honors her mother with a simple bequest and aids Alzheimer's patients April 15, 2009
What I found out and what many people don't know is that we have—in our own backyards—one of the top doctors and top centers in the world dedicated to both patient care and research for Alzheimer's…
Experimental pill shows promise fighting Alzheimer's Nov. 17, 2008
Experimental pill shows promise fighting Alzheimer's An experimental pill is causing a buzz among scientists who study Alzheimer's Disease. A handful of drugs already on the market help to stabilize patients.
New Alzheimer's pill creating a stir Nov. 3, 2008
A new pill is causing a buzz among scientists who study Alzheimer's disease. While there are a handful of drugs on the market that help stabilize Alzheimer's patients, only Dimebon offers them the hope of regaining lost cognitive abilities.
Drugs may slow progress of Alzheimer's Aug. 3, 2008
Studies reported at this week's international conference on Alzheimer's disease in Chicago say several new drugs show promise in slowing the progress of Alzheimer's more than currently approved drugs — at least in preliminary human trials.
Alzheimer's research brings progress, setbacks July 19, 2008
It's one step forward, one step back in the search for treatments against Alzheimer's disease. In one of two studies in the July 19 issue of The Lancet, an older drug called dimebon significantly improved Alzheimer's symptoms. But in a second report, a…
Allergy drug turned Alzheimer's therapy shows promise July 17, 2008
A pill once used as an antihistamine in Russia has shown a slight but unique promise for treating Alzheimer's disease and is now on a fast track to drug studies in the United States. The drug, called Dimebon, appeared to slow memory loss in patients with mild to moderate Alzheimer's disease. But,…
Antihistamine looks promising for Alzheimer's patients July 17, 2008
Alzheimer's disease can be heartbreaking to watch and frustrating to treat. Most medicines on the market do little more than delay the inevitable mental decline. But a new drug called Dimebon appears to stop and perhaps even reverse the symptoms of the cruel and degenerative disease, according to a…
Early study reveals promising Alzheimer's disease treatment July 17, 2008
A drug once approved as an antihistamine in Russia improved thinking processes and ability to function in patients with Alzheimer's disease in a study conducted there, said an expert at Baylor College of Medicine in Houston.
Myriad genetics stops work on Alzheimer's drug July 1, 2008
Flurizan, a drug developed by Myriad Genetics to treat Alzheimer's disease, failed in a closely watched late-stage clinical trial, dealing another blow to efforts to combat the illness.
Alzheimer's drug trials offer promising results March 23, 2008
Decades of work in the laboratory may finally be paying off for Alzheimer's disease patients, as clinical trials show a variety of drugs making headway against the illness. Two drugs, Dimebon and the diabetes medication Avandia, may help curb Alzheimer's in…
Blood test may predict Alzheimer's disease Oct. 14, 2007
Alzheimer's experts are optimistic that a new type of blood test could one day allow doctors to accurately predict one's risk of developing the degenerative disease. While prior research has suggested that imaging techniques and tests on spinal fluid could also be used to predict the risk of…
Mitchell uses legendary drive to improve health care July 15, 2007
George P. Mitchell thinks a lot about the future. He not only wonders about his own future, but also about the future of society and humanity in general.
Bracing for the Alzheimer's surge June 14, 2007
"It's very sad. It's a very sad disease. It's sad to watch. It's sad when she asks who you are [and] doesn't remember her own grandson, but that's part of the progression."
Antihistamine shows promise in treating Alzheimer's June 11, 2007
Dimebon, a drug long used as an antihistamine in Russia, is showing what some say are surprisingly strong results in treating Alzheimer's disease.
The politics of Alzheimer's March 15, 2007
Alzheimer's Awareness Day on Feb. 6, 2007, was not just another day at the office for Baylor College of Medicine Alzheimer's expert Rachelle Doody, M.D., Ph.D. Instead of attending to patients in her clinic as usual, she was roaming the halls of the Texas Capitol building, trying her hand at "academic lobbying."
Doctor researches Alzheimer's disease Nov. 2, 2006
Dr. Rachelle Doody was recognized Oct. 11 by The Seniors Place, 2714 Joanel, an adult day care center for Alzheimer's patients, for her work with Alzheimer's disease.
Physician aids Alzheimer's research Nov. 2, 2006
When Dr. Rachelle Doody opened an Alzheimer's disease research clinic for Baylor College of Medicine in 1989, she had no idea what her practice would become.
Symposium to provide update on Alzheimer's research Aug. 29, 2006
A free educational symposium on Alzheimer's disease will take place Thursday, featuring a neurology expert from Baylor College of Medicine in Houston.
Drug promising for advanced Alzheimer's March 27, 2006
An experimental treatment for Alzheimer's may allow treatment at a later stage than other medications, but some experts question the drug's benefits. The drug, known as Memantine, has been on the market for a decade in Germany and was recently recommended for approval by the European Union's…
Doctors not surprised by 11 patient deaths in dementia drug trial March 17, 2006
Doctors were not surprised to hear the news that 11 people in a clinical trial died while taking Aricept, a drug currently approved for use for patients with Alzheimer's disease. What was surprising, they said, was the lack of deaths in the placebo group.
The Cynthia and George Mitchell Foundation supports Alzheimer's research Oct. 15, 2005
Baylor College of Medicine is privileged to count Cynthia and George Mitchell among its most loyal and generous supporters.
New hope for Alzheimer's sufferers? April 18, 2005
Alzheimer's disease, the neurological disorder that affects some 5 million Americans, may in some cases be preceded by an ailment called mild cognitive impairment. But some researchers are skeptical that MCI, marked by the progressive loss of memory, is even a real disorder.
Doody named to Cain Chair in Alzheimer's research Feb. 16, 2005
Baylor College of Medicine's Board of Trustees has appointed Dr. Rachelle Doody to become the Effie Marie Cain Chair in Alzheimer's Disease Research.
Patients with more severe Alzheimer's may benefit from new treatment Nov. 16, 2004
Patients in the moderate to severe stages of Alzheimer's disease may benefit from a new drug available in pharmacies this month.
Neuroimaging initiative to track early signs of Alzheimer's disease Oct. 19, 2004
Researchers are looking for ways to spot early warning signs in the brain of developing Alzheimer's disease.
Early diagnosis of memory problems key to treatment Sept. 15, 2004
Last night you went to see a movie with what's-his-name.
Stem cell research plays small role in Alzheimer's research July 9, 2004
As proponents of stem cell research rally behind hopes of curing Alzheimer's disease, the answers likely lie elsewhere.
Alzheimer's patients benefiting from Baylor testing Jan. 31, 2004
It won't be just my name or who I am (that he forgets), it's going to be how to eat, daily activities. Mematine, used in clinical trials at Baylor's Alzheimer's Disease Center in 2001 and 2002, is the first member of a new class of medications…
Fish in diet of elderly may help ward off Alzheimer's July 22, 2003
The meals included tuna sandwiches, fish sticks and shellfish; the amounts eaten were not specified. The researchers found an association between eating fish and a reduced risk of Alzheimer's even after adjusting for age, sex, ethnicity and risk factors like heart disease.
Hormone therapy increases risk of dementia June 15, 2003
Taking the hormones estrogen and progestin does not protect memory and increases the risk for developing dementia in older, post-menopausal women according to the Women's Health Initiative Memory Study published in the May 28 issue of the Journal of the American Medical Association.
Advanced stages of Alzheimer's targeted April 3, 2003
A drug that delays mental deterioration in Alzheimer's patients would be the first effective treatment for advanced stages of the brain-robbing disease, according to a study conducted at Baylor College of Medicine and other centers.
Cholesterol-lowering drug offers hope for Alzheimer's patients Feb. 15, 2003
A standard treatment for ailing hearts may also help heal ailing minds.
New standards for Alzheimer's treatment Sept. 3, 2002
Research Briefs: Quieting nerves - how an epilepsy drug works, Molecular 'motor' for rotavirus, Gene therapy may encourage blood vessel growth, New standards for Alzheimer's treatment.
Testosterone may help fight Alzheimer's Jan. 24, 2002
Testosterone, the hormone associated with "manly" behavior, aggression and increased sex drive, could play a role in fighting Alzheimer's disease. In a new study conducted with female rats at The University of Texas Medical School at Houston, testosterone injections prevented a key biochemical abnormality occurring in the disease.
Baylor studies Alzheimer's vaccine Jan. 8, 2002
An experimental vaccine for people with mild to moderate Alzheimer's disease is undergoing phase II clinical trials at Baylor College of Medicine.